4891 SB
Generic Name: ropinirole
Pill imprint 4891 SB has been identified as Requip 0.5 mg.
Requip is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Requip 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Requip Images
- Generic Name:
- ropinirole
- Imprint:
-
4891
SB - Strength:
- 0.5 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Five-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
polyethylene glycol 400
titanium dioxide
ferric oxide yellow
ferric oxide red
indigotindisulfonate sodium
FD&C Blue No. 2
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4891
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-0607 | Physicians Total Care Inc (repackager) |
| 35356-0523 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.


